Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

Better than X-Rays: A More Powerful Terahertz Imaging System

April 5, 2013 8:58 pm | by I-Micronews | News | Comments

Low-energy terahertz radiation could potentially enable doctors to see deep into tissues without the damaging effects of X-rays, or allow security guards to identify chemicals in a package without opening it. But it's been difficult for engineers to make powerful enough systems to accomplish these promising applications.

Analogic Demonstrates Its Expanded Suite of Ultrasound Solutions at AIUM 2013 Annual Convention

April 5, 2013 8:45 pm | by GlobeNewswire | News | Comments

Analogic Corporation, enabling the world's medical imaging and aviation security technology, announced that it is showcasing, for the first time in the U.S., its BK Medical Flex Focus™ 500 ultrasound system, the SonixTablet with GPS needle guidance, and the SonixTouch Research systems together at the American Institute of Ultrasound in Medicine (AIUM) 2013 Annual Convention.

Awake Imaging Device Moves Diagnostics Field Forward

April 4, 2013 4:53 pm | by Oak Ridge National Laboratory | News | Comments

A technology being developed at the Department of Energy's Oak Ridge National Laboratory promises to provide clear images of the brains of children, the elderly, and people with Parkinson's and other diseases without the use of uncomfortable or intrusive restraints.

Advertisement

Next-Generation Circulating Tumor Cell Test Demonstrates High Efficiency and Accuracy in New Study

April 3, 2013 2:45 pm | by Bio-Medicine.Org | News | Comments

RARITAN, N.J. , April 3, 2013 /- Veridex, LLC (Veridex) announced today that the first study of the company's next-generation circulating tumor cell (CTC) technology, developed in collaboration with researchers at Massachusetts General Hospital (MGH), has been published in Science Translational Medicine .  The collaboration, initially announced in January 2011, has led to t...

Device Finds Stray Cancer Cells in Patients’ Blood

April 3, 2013 2:15 pm | by Massachusetts Institute of Technology | News | Comments

Doctors typically diagnose cancer via a biopsy, which can be invasive and expensive. A better way to diagnose the disease would be to detect telltale tumor cells floating in the bloodstream, but such a test has proved difficult to develop because stray cancer cells are rare, and it’s difficult to separate them from the mélange of cells in circulation.

Mindray Medical to Exhibit New Products at 69th China International Medical Equipment Fair

April 3, 2013 8:01 am | by The Associated Press | News | Comments

Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it will exhibit more than 60 products at the 69th China International Medical Equipment Fair ("CMEF") in Shenzhen, Chinabetween April...

Serascience Launches World’s First Point-of-Care Diagnostic Device for Multiple Myeloma

April 2, 2013 11:48 am | by Serascience | News | Comments

Serascience Limited, a specialist cancer diagnostics company established by a joint venture between Abingdon Health and the University of Birmingham, today announces the launch of Seralite, its proprietary point-of-care diagnostic device for multiple myeloma.

Recent Advancements Made in Diagnosing and Treating Heart Failure Could Save and Improve the Lives of Millions

April 2, 2013 9:01 am | by The Associated Press | News | Comments

SAN DIEGO--(BUSINESS WIRE)--Apr 2, 2013--As recently reported in the Journal of the American College of Cardiology, a Cleveland Clinic pilot study of 41 patients indicated that an experimental breath analysis device may be able to help diagnose patients with heart failure. In much the same way as...

Advertisement

Peer-Reviewed Study Confirms VeriStrat Test from Biodesix Provides Useful Information for Physicians in Managing Patients with Lung Cancer

April 2, 2013 8:00 am | by The Associated Press | News | Comments

BOULDER, Colo.--(BUSINESS WIRE)--Apr 2, 2013--Biodesix, Inc., a molecular diagnostic company dedicated to personalizing medicine, today announced the online release of a peer-reviewed study demonstrating that physicians are using the company's VeriStrat test to help guide treatment decisions for...

Seventh Sense Biosystems Announces Initiation of Registration Trial for Painless TAP Blood Collection Device

April 2, 2013 7:30 am | by The Associated Press | News | Comments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 2, 2013--Seventh Sense Biosystems, a privately held medical device company developing integrated blood micro-collection and analysis platforms, announced today that it has initiated a registration trial for its painless TAP™ (Touch Activated Phlebotomy) blood...

LabCorp Announces the Availability of Expanded Services for Inflammatory Bowel Disease

April 1, 2013 6:15 am | by The Associated Press | News | Comments

BURLINGTON, N.C.--(BUSINESS WIRE)--Apr 1, 2013--Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the availability of an expanded testing menu to help clinicians diagnose, treat and monitor the course of Inflammatory Bowel Disease (IBD). Gastrointestinal (GI)...

New Metabolite-based Diagnostic Test Could Help Detect Pancreatic Cancer Early

March 29, 2013 9:00 am | by AACR | News | Comments

A new diagnostic test that uses a scientific technique known as metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection. Researchers examined the utility of metabolomic analysis as a diagnostic method for pancreatic cancer and then validated the new approach...

Neuro Kinetics Releases New Version of VEST(TM) Control & Analysis Software

March 28, 2013 5:03 pm | by The Associated Press | News | Comments

Medical device manufacturer Neuro Kinetics, Inc., (NKI) will showcase the latest version of its VEST™ control and analysis software at the American Academy of Audiology's AudiologyNOW! 2013 conference next week in Anaheim, California. The...

Advertisement

How to Make a Computer from a Living Cell

March 28, 2013 4:02 pm | by Massachusetts Institute of Technology | News | Comments

If biologists could put computational controls inside living cells, they could program them to sense and report on the presence of cancer, create drugs on site as they’re needed, or dynamically adjust their activities in fermentation tanks used to make drugs and other chemicals. Now researchers at Stanford University have developed a way to make genetic parts that can perform the logic calculations that might someday control such activities.

MicroRNA Detection on the Cheap

March 28, 2013 3:58 pm | by MIT | News | Comments

Current methods of detecting microRNA (miRNA) — gene-regulating molecules implicated in the onset of various diseases — can be time-consuming and costly: The custom equipment used in such tests costs more than $100,000, and the limited throughput of these systems further hinders progress.

T2 Biosystems' Series E Round Reaches $40M

March 28, 2013 11:11 am | by Mass Device | News | Comments

T2 Biosystems reels in a $40 million Series E round for its MR-based molecular diagnostic test for the Candida fungus, a leading cause of hospital-acquired infections. T2 Biosystems, which is developing a diagnostic device that uses magnetic resonance technology to deliver nearly instant test results, said it raised a $40 million Series E round it plans to use for its T2Candida test for a common cause of hospital-acquired infections.

TE-Cooled MPPC Module

March 27, 2013 10:03 am | by MDT Staff | Hamamatsu Corp. | Product Releases | Comments

Hamamatsu Photonics introduce the new C11208 MPPC module which integrates the S11028 series MPPC, a pixelated silicon avalanche photodiode operated in Geiger-mode, with the addition of a high performance thermoelectric cooler.

Lyme Disease and Nanotubes, Paving Way for Diagnostic Device

March 27, 2013 9:45 am | by University of Pennsylvania | News | Comments

Early diagnosis is critical in treating Lyme disease. However, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection.

Trovagene Launches Urine-Based HPV Test

March 27, 2013 5:07 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , March 27, 2013 /- Trovagene, Inc. (NASDAQ:  TROV), today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus (HPV) test. The non-invasive test is designed to accurately identify the presence or absence of 15 known high-risk HPV strains using proprietary DNA sequences.

Guidance for Industry and Food and Drug Administration Staff - Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection of Antibodies to Borrelia burgdorferi

March 27, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

FDA is issuing this guidance to provide industry and agency staff with recommendations for studies to establish the analytical and clinical performance of in vitro diagnostic devices (IVDs) intended for the detection of antibodies to Borrelia burgdorferi.

More Light! – for Medicine

March 26, 2013 12:27 pm | by Forschungsverbund Berlin e.V. | News | Comments

PET scan, CT, and MRI are almost standard in today’s diagnostics – highly developed and very sophisticated. Although more capable and less cost-intensive, laser-optical diagnosis methods are, up to now, far less prevalent. FAMOS is aiming to change this.

Quinte Health Care Chooses Amcom Software for Critical Test Results Management

March 26, 2013 9:00 am | by The Associated Press | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Mar 26, 2013--Amcom Software, Inc. today announced Quinte Health Care (QHC) will use the Amcom® Critical Test Results Management (CTRM) solution to save time and improve patient safety and quality of care. The Ontario, Canada-based organization selected Amcom to...

UCLA Relies on Breakthrough ‘Big Data’ Technology from IBM To Help Patients with Traumatic Brain Injuries

March 25, 2013 11:20 pm | by IBM | News | Comments

IBM, and Excel Medical Electronics (EME) are collaborating with the UCLA Department of Neurosurgery in a study to test the effectiveness of a real-time alarm intended to predict rising brain pressure in patients with traumatic brain injuries. The experimental system uses big data analytics software developed by IBM Research and EME that analyzes in real-time streams of vital signs continuously collected from the bedside monitor...

OraQuick® Launches "Make Knowing Your Thing Today" Campaign to Promote the Importance of Knowing Your HIV Status

March 25, 2013 2:34 pm | by PR Newswire | News | Comments

LOS ANGELES, March 25, 2013 /PRNewswire/ -- OraSure Technologies, Inc. (NASDAQ:OSUR), maker of the OraQuick® In-Home HIV Test, announced today the launch of a nationwide awareness campaign to encourage everyone to learn their HIV status. The campaign, "Make Knowing Your...

FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients

March 22, 2013 7:07 pm | by The Associated Press | News | Comments

GE Healthcare today announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView™ (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s mortality risk.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading